SecSonar.com

Praxis Precision Medicines, Inc. (PRAX)

Praxis Precision Medicines, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Praxis Precision Medicines, Inc. (PRAX) is a Biotechnology company based in US with a market capitalization of $7.2B. Free cash flow was negative at -$249.1M. This page tracks PRAX's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 116 employees · IPO Oct 16, 2020

Valuation

Valuation & price

$342.58 · as of May 17, 2026 · -4.1% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

8.19

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$353$196$39.42Jul 25Dec 25Jul 26Jul 7, 25$46.68Jul 9, 25$50.20Jul 11, 25$50.54Jul 15, 25$51.89Jul 17, 25$54.94Jul 21, 25$55.16Jul 23, 25$57.09Jul 25, 25$59.22Jul 29, 25$55.96Jul 31, 25$54.22Aug 4, 25$51.09Aug 6, 25$48.60Aug 11, 25$44.95Aug 13, 25$49.05Aug 15, 25$47.08Aug 19, 25$44.80Aug 21, 25$46.38Aug 25, 25$46.94Aug 27, 25$46.92Aug 29, 25$45.54Sep 3, 25$46.55Sep 5, 25$46.85Sep 9, 25$40.03Sep 11, 25$39.42Sep 16, 25$42.00Sep 18, 25$45.23Sep 22, 25$48.33Sep 24, 25$48.97Sep 26, 25$52.44Sep 30, 25$53.00Oct 2, 25$55.19Oct 6, 25$50.98Oct 8, 25$54.29Oct 10, 25$53.26Oct 14, 25$52.52Oct 16, 25$162.71Oct 21, 25$190.02Oct 23, 25$178.01Oct 27, 25$185.94Oct 29, 25$195.76Oct 31, 25$198.76Nov 4, 25$171.75Nov 6, 25$172.35Nov 10, 25$167.89Nov 12, 25$183.61Nov 14, 25$186.42Nov 18, 25$184.13Nov 20, 25$164.09Nov 25, 25$184.25Nov 28, 25$196.46Dec 2, 25$179.12Dec 4, 25$189.97Dec 8, 25$270.98Dec 10, 25$261.58Dec 12, 25$268.80Dec 16, 25$274.51Dec 18, 25$269.26Dec 22, 25$280.40Dec 24, 25$274.76Dec 29, 25$304.58Jan 2, 26$286.40Jan 6, 26$272.90Jan 8, 26$294.38Jan 12, 26$275.74Jan 14, 26$298.46Jan 16, 26$317.25Jan 21, 26$312.60Jan 23, 26$311.71Jan 27, 26$314.75Jan 29, 26$314.28Feb 2, 26$309.11Feb 4, 26$303.34Feb 9, 26$319.54Feb 11, 26$323.29Feb 13, 26$317.25Feb 18, 26$328.93Feb 20, 26$335.28Feb 24, 26$342.71Feb 26, 26$340.47Mar 2, 26$330.59Mar 4, 26$325.11Mar 6, 26$310.71Mar 10, 26$309.91Mar 12, 26$303.37Mar 17, 26$303.38Mar 19, 26$297.50Mar 23, 26$294.11Mar 25, 26$311.92Mar 27, 26$290.10Mar 31, 26$322.19Apr 2, 26$310.38Apr 7, 26$306.69Apr 9, 26$320.24Apr 13, 26$317.00Apr 15, 26$339.93Apr 17, 26$342.50Apr 22, 26$337.29Apr 24, 26$344.82Apr 28, 26$321.92Apr 30, 26$318.83May 4, 26$337.61May 6, 26$338.07May 8, 26$330.02May 12, 26$343.20May 14, 26$345.52May 18, 26$320.53May 20, 26$335.61May 22, 26$343.56May 28, 26$352.63Jun 1, 26$335.16Jun 3, 26$278.93Jun 5, 26$254.00Jun 9, 26$250.33Jun 11, 26$247.98Jun 15, 26$264.54Jun 17, 26$270.01Jun 22, 26$303.39Jun 24, 26$308.94Jun 26, 26$327.79Jul 2, 26$318.52
$37.7152-week range$357.13
Loading valuation history…

Fundamentals

Key fundamentals

$7.2B

Market cap

—

Revenue growth (YoY)

-1682.0%

Gross margin

-$249.1M

Free cash flow (USD)

-$599.2M

Net debt

Net cash position

25.7%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2018 → 2025

FY 2018$0.00FY 2019$0.00FY 2020$0.00FY 2021$0.00FY 2022$0.00FY 2023$2.4MFY 2024$8.6MFY 2025$0.00
$0$0

Free cash flow by year

2018 → 2025

FY 2018$-20.8MFY 2019$-32.9MFY 2020$-52.6MFY 2021$-125.6MFY 2022$-185.5MFY 2023$-111.2MFY 2024$-131.8MFY 2025$-249.1M
-$20.8M-$249.1M

Gross margin by year

2023 → 2024

FY 2023-3445.8%FY 2024-1682.0%
-3445.8%-1682.0%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

1

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 7, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventAccounting Firm ChangeJul 2, 2026Filing
  • 8-K eventFDA Review ExtensionJun 29, 2026Filing
  • Insider sellInsider Sell $3.6M · 10b5-1 PlanDeSimone Jill · Director · $3.6MJun 26, 2026Filing
  • 8-K eventBreakthrough Therapy DesignationJun 22, 2026Filing
  • 8-K eventAnnual Meeting ResultsJun 12, 2026Filing
  • 8-K eventClinical Study ResultsJun 1, 2026Filing
  • Quarterly report10-Q FiledMay 7, 2026Filing
  • 8-K eventCorporate Update and Financial ResultsMay 7, 2026Filing
  • 8-K eventNew Drug Application AcceptedApr 14, 2026Filing
  • 8-K eventClinical Trial ResultsApr 6, 2026Filing

Questions

Frequently asked questions

What is Praxis Precision Medicines, Inc.'s market cap?

Praxis Precision Medicines, Inc. (PRAX) has a market capitalization of $7.2B.

What is PRAX's P/E ratio?

A meaningful P/E ratio is not available for PRAX — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is PRAX's price-to-book (P/B) ratio?

PRAX trades at 8.19 times book value per share.

Are insiders buying PRAX stock?

SEC Form 4 filings show no open-market insider buys at Praxis Precision Medicines, Inc. in the last 90 days (1 sell).

Same arena

Related companies in Biotechnology

ALKS

Alkermes plc

$7.1B

CORT

Corcept Therapeutics Incorporated

$7.5B

KYMR

Kymera Therapeutics, Inc.

$6.7B

IBRX

ImmunityBio, Inc.

$7.9B

HALO

Halozyme Therapeutics, Inc.

$8B

PTGX

Protagonist Therapeutics, Inc.

$6.4B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.